Top

Journal of Neurology

Published in:

01-10-2013 | Letter to the Editors

4-Aminopyridine improves freezing of gait in Parkinson’s disease

Authors: Corneliu C. Luca, Carlos Singer

Published in: Journal of Neurology | Issue 10/2013

Excerpt

Dear Sirs, …

Nutt JG, Horak FB, Bloem BR (2011) Milestones in gait, balance, and falling. Mov Disord 26(6):1166–1174PubMedCrossRef

Chung KA, Lobb BM, Nutt JG, Horak FB (2010) Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology 75(14):1263–1269PubMedCrossRef

Moreau C, Delval A, Defebvre L, Dujardin K, Duhamel A, Petyt G et al (2012) Methylphenidate for gait hypokinesia and freezing in patients with Parkinson’s disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial. Lancet Neurol 11(7):589–596PubMedCrossRef

Chan H, Kukkle PL, Merello M, Lim S, Poon Y, Moro E (2013) Amantadine improves gait in PD patients with STN stimulation. Parkinsonism Relat Disord 19(3):316–319PubMedCrossRef

Goodman AD, Stone RT (2013) Enhancing neural transmission in multiple sclerosis (4-aminopyridine therapy). Neurotherapeutics 10(1):106–110PubMedCrossRef

Luca CC, Singer C (2013) Can 4-aminopyridine modulate dysfunctional gait networks in Parkinson’s disease? Parkinsonism Relat Disord 19(9):777–782PubMedCrossRef

Wolfe DL, Hayes KC, Hsieh JT, Potter PJ (2001) Effects of 4-aminopyridine on motor evoked potentials in patients with spinal cord injury: a double-blinded, placebo-controlled crossover trial. J Neurotrauma 18(8):757–771PubMedCrossRef

Strupp M, Schüler O, Krafczyk S, Jahn K, Schautzer F, Büttner U et al (2003) Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study. Neurology 61(2):165–170PubMedCrossRef

Strupp M, Kalla R, Claassen J, Adrion C, Mansmann U, Klopstock T et al (2011) A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology 77(3):269–275PubMedCrossRef

10.

Schniepp R, Wuehr M, Neuhaeusser M, Benecke AK, Adrion C, Brandt T et al (2012) 4-Aminopyridine and cerebellar gait: a retrospective case series. J Neurol 259(11):2491–2493PubMedCrossRef

11.

Shine JM, Matar E, Ward PB, Bolitho SJ, Gilat M, Pearson M et al (2013) Exploring the cortical and subcortical functional magnetic resonance imaging changes associated with freezing in Parkinson’s disease. Brain 136(4):1204–1215PubMedCrossRef

12.

Mainero C, Inghilleri M, Pantano P, Conte A, Lenzi D, Frasca V et al (2004) Enhanced brain motor activity in patients with MS after a single dose of 3,4-diaminopyridine. Neurology 62(11):2044–2050PubMedCrossRef

Title: 4-Aminopyridine improves freezing of gait in Parkinson’s disease
Authors: Corneliu C. Luca
Carlos Singer
Publication date: 01-10-2013
Publisher: Springer Berlin Heidelberg
Published in: Journal of Neurology / Issue 10/2013
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-013-7090-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

4-Aminopyridine improves freezing of gait in Parkinson’s disease

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 10/2013

Obstetrical epidural and spinal anesthesia in multiple sclerosis

Cluster headache and oxygen: is it possible to predict which patients will be relieved? A prospective cross-sectional correlation study

Inherited neuropathies: an update

Diagnostic odyssey of patients with myotonic dystrophy

The risk stratification based on the CHA2DS2-VASc may predict the response to intravenous thrombolysis after stroke

Brain white matter diffusion tensor metrics from clinical 1.5T MRI distinguish between ALS phenotypes